34 Results for "

macrocyclic compounds

" in MedChemExpress (MCE) Product Catalog:
Products (34)

34 Results for "macrocyclic compounds" in MCE Product Catalog:

Cat. No.: HY-W034566
CAS No.: 296-35-5
Synonyms: Hexaaza-18-crown-6; 1,4,7,10,13,16-Hexaazacyclooctadecane
Hexacyclen is an organic compound with a unique macrocyclic structure composed of six nitrogen-containing rings. It is commonly used as a chelating agent in chemistry and biochemistry due to its ability to bind metal ions. Inhibitors of certain diseases such as cancer. In biochemistry, Hexacyclen is often used to selectively bind metal ions in proteins or enzymes to study their structure and function. Due to its large size and complex structure, Hexacyclen is not widely used in daily products or applications .
loading...
    loading...
Cat. No.: HY-130423
CAS No.: 51596-10-2
Purity:  99.46%
Target:  

Insecticide

Research Areas:  

Infection

Milbemycin A3 is a 16-membered macrocyclic lactone compound found in the soil bacterium Saccharopolyspora hygroscopicus subsp. aureolacrimosus. Milbemycin A3 enhances the opening of glutamate- and GABA-gated chloride channels and exhibits insecticidal activity. Milbemycin A3 can be used in insect resistance-related research .
loading...
    loading...
Cat. No.: HY-103048A
Purity:  99.34%
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

PD-1/PD-L1-IN 3 TFA, a macrocyclic peptide, is a potent and selective inhibitor of the PD-1/PD-L1 and CD80/PD-L1 interactions extracted from patent WO2014151634A1, compound No.1. PD-1/PD-L1-IN 3 TFA interferes with PD-L1 binding to PD-1 and CD80 by binding to PD-L1, with IC50s of 5.60 nM and 7.04 nM, respectively. PD-1/PD-L1-IN 3 TFA can be used for the research of various diseases, including cancer and infectious diseases .
loading...
    loading...
Cat. No.: HY-N12730
CAS No.: 81557-52-0
Euphoscopin B (compound 5) is a cytotoxic macrocyclic diterpene isolated from Euphorbia helioscopia L .
loading...
    loading...
Cat. No.: HY-173076A
Target:  

HDAC YAP

Research Areas:  

Inflammation/Immunology

HDAC11-IN-1 (Compound 14-N C6OH) TFA is a selective macrocyclic inhibitor of HDAC11 with a Ki of 40 nM. HDAC11-IN-1 TFA exhibits good cell permeability and can inhibit the expression of YAP1 and SOX2 .
loading...
    loading...
Cat. No.: HY-103048
CAS No.: 1629654-95-0
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

PD-1/PD-L1-IN 3, a macrocyclic peptide, is a potent and selective inhibitor of the PD-1/PD-L1 and CD80/PD-L1 interactions extracted from patent WO2014151634A1, compound No.1. PD-1/PD-L1-IN 3 interferes with PD-L1 binding to PD-1 and CD80 by binding to PD-L1, with IC50s of 5.60 nM and 7.04 nM, respectively. PD-1/PD-L1-IN 3 can be used for the research of various diseases, including cancer and infectious diseases .
loading...
    loading...
Cat. No.: HY-162234
CAS No.: 2948289-20-9
Target:  

PKC

Research Areas:  

Others

PKCTheta-IN-1 (Compound 19) is a selective macrocyclic PKCTheta inhibitor with IC50 value of 0.1 nM .
loading...
    loading...
Cat. No.: HY-178936
CAS No.: 3094174-82-7
Target:  

JAK STAT

Research Areas:  

Inflammation/Immunology Cancer

JAK2-IN-15 is an orally active, potent, selective JAK2 inhibitor (IC50 = 1.17 nM). JAK2-IN-15 can inhibit the AK2-STAT signaling pathway. JAK2-IN-15 significantly improves key pathological indicators such as hematocrit and splenomegaly in an Epoetin beta (HY-114134) (rhEPO)-induced mouse model. JAK2-IN-15 can be used for the study of Polycythemia Vera (PV) .
loading...
    loading...
Cat. No.: HY-161096
CAS No.: 3034861-58-7
Target:  

ROR

Research Areas:  

Cancer

Antitumor agent-127 (compound 1) is a parent macrocyclic peptide. Antitumor agent-127 displays nanomolar cell-based binding to ROR1 and relatively good internalization in 786-O and MDA-MB-231 tumor cell lines .
loading...
    loading...
Cat. No.: HY-P10767
CAS No.: 2468971-42-6
Target:  

Neurotensin Receptor

Research Areas:  

Neurological Disease

MD01-67 is a selective macrocyclic compound targeting the neurotensin receptor type 2 (NTS2), with Ki of 2.9 nM. MD01-67 exhibits analgesic and tactile hypersensitivity reducing activity in rats acute/persistent/chronic inflammatory pain models .
loading...
    loading...
Cat. No.: HY-W127809
CAS No.: 550-52-7
Chlorin e4 is an organic compound belonging to the family of chlorins, which are macrocyclic compounds with a similar structure to porphyrins. It is commonly used to improve photodynamic therapy for cancer and other diseases. Chlorin e4 has multiple applications in medical research, including as a photosensitizer for localized tumor destruction. In addition, its antimicrobial properties and potential use in disinfection applications were investigated.
loading...
    loading...
Cat. No.: HY-133015
CAS No.: 2376774-73-9
Target:  

Bcl-2 Family

Research Areas:  

Cancer

Mcl-1 inhibitor 3 (compound 1) is a highly potent and orally activate macrocyclic Mcl-1 inhibitor (Ki= 0.061 nM; IC50=19 nM in an OPM-2 cell viability assay). Mcl-1 inhibitor 3 shows good pharmacokinetic properties and excellent in vivo efficacy without toxicity .
.
loading...
    loading...
Cat. No.: HY-161370
CAS No.: 2574390-19-3
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

VD4162 (Compound 8b) is a macrocyclic inhibitor of serine proteases. VD4162 can significantly improve potency for all four target enzymes TMPRSS2 (IC50 = 3.7 nM), HGFA(IC50 = 3.3 nM), matriptase (IC50 = 2.9 nM), and hepsin (IC50 = 0.54 nM). VD4162 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-178501
Target:  

Ras

Research Areas:  

Cancer

KRAS-IN-45 (Compound 1.019) is a KRAS inhibitor. KRAS-IN-45 can be used for the study of cancers .
loading...
    loading...
Cat. No.: HY-178502
Target:  

Ras

Research Areas:  

Cancer

KRAS-IN-46 (Compound 1.013) is a KRAS inhibitor. KRAS-IN-46 can be used for the study of cancers .
loading...
    loading...
Cat. No.: HY-P3347
CAS No.: 2891469-81-9
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

NH2-c[X-R-L-S-X]-K-G-P-(D-2Nal) (compound 40), a macrocyclic analogue of Ape13, is a potent APJ agonist (Ki=5.7 nM). NH2-c[X-R-L-S-X]-K-G-P-(D-2Nal) exhibits a favorable Gα12-biased signaling and an increased in vivo half-life .
loading...
    loading...
Cat. No.: HY-158150
Target:  

Proteasome

Research Areas:  

Cancer

20S Proteasome-IN-5 (Compound 5) is a macrocyclic inhibitor of the 20S Proteasome, with IC50 values of 0.19 and 52.5 μM for ChT-L and PGPH-L activity, respectively .
loading...
    loading...
Cat. No.: HY-N13181
CAS No.: 213903-67-4
2-(3',4'-Dihydroxyphenyl)-1,3-benzodioxole-5-aldehyde is a macrocyclic glycoside compound derived from Sargentodoxa cuneata, exhibiting significant antioxidant activity with a DPPH IC50 value of 2.9 μM .
loading...
    loading...
Cat. No.: HY-173076
Target:  

HDAC YAP

Research Areas:  

Inflammation/Immunology

HDAC11-IN-1 (Compound 14-N C6OH) is a selective macrocyclic inhibitor of HDAC11 with a Ki of 40 nM. HDAC11-IN-1 exhibits good cell permeability and can inhibit the expression of YAP1 and SOX2 .
loading...
    loading...
Cat. No.: HY-168902
Target:  

Proteasome

Research Areas:  

Cancer

Proteasome-IN-7 (Compound 6f) is an epoxyketone macrocyclic peptidyl proteasome inhibitor (IC50 value of 37.92 nM for 20S proteasome ChT-L subunit). Proteasome-IN-7 displays robust antiproliferative effects against multiple myeloma, acute lymphoblastic leukemia and non-small cell lung cancer .
loading...
    loading...